Caplin Point Laboratories Ltd
NSE:CAPLIPOINT

Watchlist Manager
Caplin Point Laboratories Ltd Logo
Caplin Point Laboratories Ltd
NSE:CAPLIPOINT
Watchlist
Price: 1 951.5 INR -0.13%
Market Cap: 148.3B INR
Have any thoughts about
Caplin Point Laboratories Ltd?
Write Note

Caplin Point Laboratories Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Caplin Point Laboratories Ltd
Total Equity Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
T
TORNTPHARM
M
MANKIND

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Caplin Point Laboratories Ltd
NSE:CAPLIPOINT
Total Equity
â‚ą23.2B
CAGR 3-Years
25%
CAGR 5-Years
30%
CAGR 10-Years
44%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Total Equity
â‚ą282.5B
CAGR 3-Years
17%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Total Equity
â‚ą283.6B
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
10%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Total Equity
â‚ą691.1B
CAGR 3-Years
12%
CAGR 5-Years
10%
CAGR 10-Years
12%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Total Equity
â‚ą75B
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
12%
M
Mankind Pharma Ltd
NSE:MANKIND
Total Equity
â‚ą93.6B
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Caplin Point Laboratories Ltd's Total Equity?
Total Equity
23.2B INR

Based on the financial report for Jun 30, 2024, Caplin Point Laboratories Ltd's Total Equity amounts to 23.2B INR.

What is Caplin Point Laboratories Ltd's Total Equity growth rate?
Total Equity CAGR 10Y
44%

Over the last year, the Total Equity growth was 23%. The average annual Total Equity growth rates for Caplin Point Laboratories Ltd have been 25% over the past three years , 30% over the past five years , and 44% over the past ten years .

Back to Top